Copyright
©2010 Baishideng. All rights reserved.
World J Gastroenterol. Feb 28, 2010; 16(8): 927-933
Published online Feb 28, 2010. doi: 10.3748/wjg.v16.i8.927
Published online Feb 28, 2010. doi: 10.3748/wjg.v16.i8.927
Surgical treatment for liver cancer
Nicole C Tsim, Adam E Frampton, Nagy A Habib, Long R Jiao, Department of Hepatopancreatobiliary Surgery, Division of Surgery, Hammersmith Hospital campus, Imperial College London, Du Cane Road, London W12 0HS, United Kingdom
Author contributions: All authors generated the ideas and contributed to the writing of this manuscript.
Supported by NIHR Biomedical Research Centre funding scheme
Correspondence to: Long R Jiao, MD, FRCS, Reader and Consultant HPB Surgeon, Department of Hepatopancreatobiliary Surgery, Division of Surgery, Hammersmith Hospital campus, Imperial College London, Du Cane Road, London W12 0HS, United Kingdom. l.jiao@imperial.ac.uk
Telephone: +44-20-83833937 Fax: +44-20-83833212
Received: March 7, 2009
Revised: December 20, 2009
Accepted: December 27, 2009
Published online: February 28, 2010
Revised: December 20, 2009
Accepted: December 27, 2009
Published online: February 28, 2010
Abstract
Primary liver cancer is amongst the commonest tumors worldwide, particularly in parts of the developing world, and is increasing in incidence. Over the past three decades, surgical hepatic resection has evolved from a high risk, resource intensive procedure with limited application, to a safe and commonly performed operation with a range of indications. This article reviews the approach to surgical resection for malignancies such as hepatocellular cancer, metastatic liver deposits and neuroendocrine tumors. Survival data after resection is also reviewed, as well as indications for curative resection.
Keywords: Liver cancer, Surgical resection, Indications, Hepatocellular carcinoma, Colorectal liver metastases, Neuroendocrine tumors, Non-colorectal non-neuroendocrine